ONCOLYTICS BIOTECH INC — Investor Relations & Filings
Filings indexed
1,037
across all filing types
Latest filing
2026-05-22
Regulatory Filings
Country
US
United States of America
Listing
US
ONCY
Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company developing pelareorep, an intravenously delivered immuno-oncolytic virus. This immunotherapeutic agent is designed to selectively replicate in cancer cells, which triggers innate and adaptive anti-tumor immune responses. By awakening the patient's immune system, pelareorep aims to enhance the efficacy of other oncology treatments, such as chemotherapy and immune checkpoint inhibitors. The company's clinical development program is evaluating its potential across various cancer types, with a focus on HR+/HER2- breast cancer and pancreatic cancer, where it has demonstrated the potential to extend survival times and reduce tumor burden.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-22 | English | |
| 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-05-04 | English | |
| 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-04-27 | English | |
| 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-04-06 | English | |
| 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-04-01 | English | |
| 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-03-20 | English |
Browse filings by year
22 years- 2026 37 filings
- 2025 59 filings
- 2024 43 filings
- 2023 34 filings
- 2022 47 filings
- 2021 35 filings
- 2020 45 filings
- 2019 40 filings
- 2018 61 filings
- 2017 39 filings
- 2016 34 filings
- 2015 52 filings
- 2014 48 filings
- 2013 34 filings
- 2012 43 filings
- 2011 52 filings
- 2010 54 filings
- 2009 73 filings
- 2008 83 filings
- 2007 67 filings
- 2006 52 filings
- 2005 5 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46825928 | 8-K | 2026-05-22 | English | ||
| 40908926 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-05-04 | English | ||
| 37436311 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-04-27 | English | ||
| 33603105 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-04-06 | English | ||
| 33135307 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-04-01 | English | ||
| 33002445 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-03-20 | English | ||
| 32986507 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-03-19 | English | ||
| 32888086 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-03-02 | English | ||
| 32888087 | 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer) | 2026-02-24 | English | ||
| 28053855 | 4 Filing | 2026-02-13 | English | ||
| 28053850 | 4 Filing | 2026-02-13 | English | ||
| 28053844 | 4 Filing | 2026-02-13 | English | ||
| 28053840 | 4 Filing | 2026-02-13 | English | ||
| 28053795 | 4 Filing | 2026-02-13 | English | ||
| 28053786 | 4 Filing | 2026-02-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOMARIN PHARMACEUTICAL INC
A global biotechnology company developing therapies for rar…
|
BMRN | US | Manufacturing |
|
BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for cl…
|
BMX | PL | Manufacturing |
|
Biomea Fusion, Inc.
A clinical-stage biopharma developing oral drugs for diabet…
|
BMEA | US | Manufacturing |
|
BIOME AUSTRALIA LIMITED
Develops and distributes evidence-based probiotics and comp…
|
BIO | AU | Manufacturing |
|
Biome Grow Inc.
Production and distribution of cannabis products focused on…
|
BIO | CA | Manufacturing |
|
BIOMERICA INC
Develops in-vitro diagnostic and therapeutic products for c…
|
BMRA | US | Manufacturing |
|
bioMérieux
A global leader in in vitro diagnostics for clinical and in…
|
BIM | FR | Manufacturing |
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
ONCOLYTICS BIOTECH INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33950/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33950 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33950 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33950 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33950}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ONCOLYTICS BIOTECH INC (id: 33950)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.